{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T18:10:09Z","timestamp":1746900609791,"version":"3.40.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,10]]},"DOI":"10.7759\/cureus.83850","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T17:37:33Z","timestamp":1746898653000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparative Efficacy of Metformin and Combined Oral Contraceptives in the Management of Adolescent Polycystic Ovary Syndrome: A Systematic Review of Randomized Controlled Trials"],"prefix":"10.7759","author":[{"given":"Aqsa","family":"Mandvia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Komal","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katee","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leen I","family":"Sabbagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amritveer","family":"Bhullar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danyah","family":"Mohamed Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikhil Deep","family":"Kolanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Polycystic ovarian disease","author":"Rasquin LI","year":"2022","unstructured":"Rasquin LI, Anastasopoulou C, Mayrin JV. Polycystic ovarian disease. StatPearls. StatPearls Publishing, Treasure Island, FL; 2022."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12041454","article-title":"Polycystic ovary syndrome: etiology, current management, and future therapeutics","volume":"12","author":"Singh S","year":"2023","unstructured":"Singh S, Pal N, Shubham S, Sarma DK, Verma V, Marotta F, Kumar M. Polycystic ovary syndrome: etiology, current management, and future therapeutics. J Clin Med. 2023, 12:1454. 10.3390\/jcm12041454","journal-title":"J Clin Med"},{"key":"ref3","article-title":"The diagnosis of polycystic ovary syndrome in adolescents","volume":"4","author":"Roe AH","year":"2011","unstructured":"Roe AH, Dokras A. The diagnosis of polycystic ovary syndrome in adolescents. Rev Obstet Gynecol. 2011, 4:45-51.","journal-title":"Rev Obstet Gynecol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2337\/diaspect.28.2.116","article-title":"The role of polycystic ovary syndrome in reproductive and metabolic health: overview and approaches for treatment","volume":"28","author":"Dennett CC","year":"2015","unstructured":"Dennett CC, Simon J. The role of polycystic ovary syndrome in reproductive and metabolic health: overview and approaches for treatment. Diabetes Spectr. 2015, 28:116-20. 10.2337\/diaspect.28.2.116","journal-title":"Diabetes Spectr"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/jhrs.JHRS_72_18","article-title":"Consensus statement on the use of oral contraceptive pills in polycystic ovarian syndrome women in India","volume":"11","author":"Shah D","year":"2018","unstructured":"Shah D, Patil M. Consensus statement on the use of oral contraceptive pills in polycystic ovarian syndrome women in India. J Hum Reprod Sci. 2018, 11:96-118. 10.4103\/jhrs.JHRS_72_18","journal-title":"J Hum Reprod Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003053.pub6","article-title":"Insulin\u2010sensitising drugs (metformin, rosiglitazone, pioglitazone, D\u2010chiro\u2010inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","volume":"11","author":"Morley LC","year":"2017","unstructured":"Morley LC, Tang T, Yasmin E, Norman RJ, Balen AH. Insulin\u2010sensitising drugs (metformin, rosiglitazone, pioglitazone, D\u2010chiro\u2010inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev. 2017, 11:CD003053. 10.1002\/14651858.CD003053.pub6","journal-title":"Cochrane Database Syst Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/1524839919893361","article-title":"A review of the PubMed PICO tool: using evidence-based practice in health education","volume":"21","author":"Brown D","year":"2020","unstructured":"Brown D. A review of the PubMed PICO tool: using evidence-based practice in health education. Health Promot Pract. 2020, 21:496-8. 10.1177\/1524839919893361","journal-title":"Health Promot Pract"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1325230","article-title":"Organokines and liver enzymes in adolescent girls with polycystic ovary syndrome during randomized treatments","volume":"15","author":"Garcia-Beltran C","year":"2024","unstructured":"Garcia-Beltran C, Peyrou M, Navarro-Gascon A, L\u00f3pez-Bermejo A, de Zegher F, Villarroya F, Ib\u00e1\u00f1ez L. Organokines and liver enzymes in adolescent girls with polycystic ovary syndrome during randomized treatments. Front Endocrinol (Lausanne). 2024, 15:1325230. 10.3389\/fendo.2024.1325230","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1125569","article-title":"Circulating follistatin concentrations in adolescent PCOS: divergent effects of randomized treatments","volume":"14","author":"D\u00edaz M","year":"2023","unstructured":"D\u00edaz M, de Zegher F, Ib\u00e1\u00f1ez L. Circulating follistatin concentrations in adolescent PCOS: divergent effects of randomized treatments. Front Endocrinol (Lausanne). 2023, 14:1125569. 10.3389\/fendo.2023.1125569","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2017.04.010","article-title":"Normalizing ovulation rate by preferential reduction of hepato-visceral fat in adolescent girls with polycystic ovary syndrome","volume":"61","author":"Ib\u00e1\u00f1ez L","year":"2017","unstructured":"Ib\u00e1\u00f1ez L, Del R\u00edo L, D\u00edaz M, Sebastiani G, Pozo \u00d3J, L\u00f3pez-Bermejo A, de Zegher F. Normalizing ovulation rate by preferential reduction of hepato-visceral fat in adolescent girls with polycystic ovary syndrome. J Adolesc Health. 2017, 61:446-53. 10.1016\/j.jadohealth.2017.04.010","journal-title":"J Adolesc Health"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2018.1460343","article-title":"Effect of 12-month treatment with metformin and\/or oral contraceptives on health-related quality of life in polycystic ovary syndrome","volume":"34","author":"Altinok ML","year":"2018","unstructured":"Altinok ML, Ravn P, Andersen M, Glintborg D. Effect of 12-month treatment with metformin and\/or oral contraceptives on health-related quality of life in polycystic ovary syndrome. Gynecol Endocrinol. 2018, 34:859-63. 10.1080\/09513590.2018.1460343","journal-title":"Gynecol Endocrinol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2014-0283","article-title":"Randomized clinical trial evaluating metformin versus oral contraceptive pills in the treatment of adolescents with polycystic ovarian syndrome","volume":"28","author":"Al-Zubeidi H","year":"2015","unstructured":"Al-Zubeidi H, Klein KO. Randomized clinical trial evaluating metformin versus oral contraceptive pills in the treatment of adolescents with polycystic ovarian syndrome. J Pediatr Endocrinol Metab. 2015, 28:853-8. 10.1515\/jpem-2014-0283","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1135","article-title":"Body composition is improved during 12 months' treatment with metformin alone or combined with oral contraceptives compared with treatment with oral contraceptives in polycystic ovary syndrome","volume":"99","author":"Glintborg D","year":"2014","unstructured":"Glintborg D, Altinok ML, Mumm H, Hermann AP, Ravn P, Andersen M. Body composition is improved during 12 months' treatment with metformin alone or combined with oral contraceptives compared with treatment with oral contraceptives in polycystic ovary syndrome. J Clin Endocrinol Metab. 2014, 99:2584-91. 10.1210\/jc.2014-1135","journal-title":"J Clin Endocrinol Metab"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-014-0103-8","article-title":"Adiponectin, interleukin-6, monocyte chemoattractant protein-1, and regional fat mass during 12-month randomized treatment with metformin and\/or oral contraceptives in polycystic ovary syndrome","volume":"37","author":"Glintborg D","year":"2014","unstructured":"Glintborg D, Mumm H, Altinok ML, Richelsen B, Bruun JM, Andersen M. Adiponectin, interleukin-6, monocyte chemoattractant protein-1, and regional fat mass during 12-month randomized treatment with metformin and\/or oral contraceptives in polycystic ovary syndrome. J Endocrinol Invest. 2014, 37:757-64. 10.1007\/s40618-014-0103-8","journal-title":"J Endocrinol Invest"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins JP","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, et al.. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011, 343:d5928. 10.1136\/bmj.d5928","journal-title":"BMJ"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.endmts.2024.100162","article-title":"A review on critical appraisal and pathogenesis of polycystic ovarian syndrome","volume":"14","author":"Hajam YA","year":"2024","unstructured":"Hajam YA, Rather HA, Neelam, Kumar K, Basheer M, Reshi MS. A review on critical appraisal and pathogenesis of polycystic ovarian syndrome. Endocr Metab Sci. 2024, 14:100162. 10.1016\/j.endmts.2024.100162","journal-title":"Endocr Metab Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmx039","article-title":"Combined oral contraceptives and\/or antiandrogens versus insulin sensitizers for polycystic ovary syndrome: a systematic review and meta-analysis","volume":"24","author":"Luque-Ram\u00edrez M","year":"2018","unstructured":"Luque-Ram\u00edrez M, Nattero-Ch\u00e1vez L, Ortiz Flores AE, Escobar-Morreale HF. Combined oral contraceptives and\/or antiandrogens versus insulin sensitizers for polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2018, 24:225-41. 10.1093\/humupd\/dmx039","journal-title":"Hum Reprod Update"},{"key":"ref19","article-title":"Oral contraceptive pills","author":"Cooper DB","year":"2024","unstructured":"Cooper DB, Patel P. Oral contraceptive pills. StatPearls. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro RS","year":"2013","unstructured":"Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013, 98:4565-92. 10.1210\/jc.2013-2350","journal-title":"J Clin Endocrinol Metab"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaa032","article-title":"Toward a treatment normalizing ovulation rate in adolescent girls with polycystic ovary syndrome","volume":"4","author":"Ib\u00e1\u00f1ez L","year":"2020","unstructured":"Ib\u00e1\u00f1ez L, D\u00edaz M, Garc\u00eda-Beltr\u00e1n C, Malpique R, Garde E, L\u00f3pez-Bermejo A, de Zegher F. Toward a treatment normalizing ovulation rate in adolescent girls with polycystic ovary syndrome. J Endocr Soc. 2020, 4:bvaa032. 10.1210\/jendso\/bvaa032","journal-title":"J Endocr Soc"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102162","article-title":"Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials","volume":"63","author":"Alesi S","year":"2023","unstructured":"Alesi S, Forslund M, Melin J, et al.. Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials. EClinicalMedicine. 2023, 63:102162. 10.1016\/j.eclinm.2023.102162","journal-title":"EClinicalMedicine"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1210\/er.2008-0030","article-title":"Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review","volume":"30","author":"Palomba S","year":"2009","unstructured":"Palomba S, Falbo A, Zullo F, Orio F Jr. Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocr Rev. 2009, 30:1-50. 10.1210\/er.2008-0030","journal-title":"Endocr Rev"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005552.pub3","article-title":"Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome","volume":"8","author":"Fraison E","year":"2020","unstructured":"Fraison E, Kostova E, Moran LJ, Bilal S, Ee CC, Venetis C, Costello MF. Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome. Cochrane Database Syst Rev. 2020, 8:CD005552. 10.1002\/14651858.CD005552.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjco.2023.12.010","article-title":"Increased prevalence of adverse health outcomes across the lifespan in those affected by polycystic ovary syndrome: a Canadian population cohort","volume":"6","author":"Vine D","year":"2023","unstructured":"Vine D, Ghosh M, Wang T, Bakal J. Increased prevalence of adverse health outcomes across the lifespan in those affected by polycystic ovary syndrome: a Canadian population cohort. CJC Open. 2023, 6:314-26. 10.1016\/j.cjco.2023.12.010","journal-title":"CJC Open"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/358086-comparative-efficacy-of-metformin-and-combined-oral-contraceptives-in-the-management-of-adolescent-polycystic-ovary-syndrome-a-systematic-review-of-randomized-controlled-trials","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T17:37:34Z","timestamp":1746898654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/358086-comparative-efficacy-of-metformin-and-combined-oral-contraceptives-in-the-management-of-adolescent-polycystic-ovary-syndrome-a-systematic-review-of-randomized-controlled-trials"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,10]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.83850","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,10]]}}}